Author
Listed:
- Gholamreza Haqshenas
(Infection & Immunity Program, Monash University)
- Jianmin Wu
(Garvan Institute of Medical Research
St Vincent’s Clinical School, University of New South Wales
Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Centre for Cancer Bioinformatics, Peking University Cancer Hospital & Institute)
- Kaylene J. Simpson
(Victorian Centre for Functional Genomics, The Peter MacCallum Cancer Centre
The University of Melbourne)
- Roger J. Daly
(Cancer Program, Monash University)
- Hans J. Netter
(Infection & Immunity Program, Monash University
Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute, Melbourne Health)
- Thomas F. Baumert
(Inserm U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Université de Strasbourg
Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg)
- Christian Doerig
(Infection & Immunity Program, Monash University)
Abstract
Host cell signalling during infection with intracellular pathogens remains poorly understood. Here we report on the use of antibody microarray technology to detect variations in the expression levels and phosphorylation status of host cell signalling proteins during hepatitis C virus (HCV) replication. Following transfection with HCV RNA, the JNK and NF-κB pathways are suppressed, while the JAK/STAT5 pathway is activated; furthermore, components of the apoptosis and cell cycle control machineries are affected in the expression and/or phosphorylation status. RNAi-based hit validation identifies components of the JAK/STAT, NF-κB, MAPK and calcium-induced pathways as modulators of HCV replication. Selective chemical inhibition of one of the identified targets, the JNK activator kinase MAP4K2, does impair HCV replication. Thus this study provides a comprehensive picture of host cell pathway mobilization by HCV and uncovers potential therapeutic targets. The strategy of identifying targets for anti-infective intervention within the host cell signalome can be applied to any intracellular pathogen.
Suggested Citation
Gholamreza Haqshenas & Jianmin Wu & Kaylene J. Simpson & Roger J. Daly & Hans J. Netter & Thomas F. Baumert & Christian Doerig, 2017.
"Signalome-wide assessment of host cell response to hepatitis C virus,"
Nature Communications, Nature, vol. 8(1), pages 1-11, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15158
DOI: 10.1038/ncomms15158
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15158. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.